C4 THERAPEUTICS INC (CCCC)
US12529R1077 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 126.59M | 29.80M | 76.10M | 181.70M | 90.50M | |||
| Marketable Securities | 127.09M | 246.40M | 233.20M | 190.00M | N/A | |||
| Receivables | 11.80M | 1.50M | 5.70M | 4.50M | 4.60M | |||
| Other Current Assets | 5.71M | 9.90M | 10.70M | 4.80M | 1.60M | |||
| Total Current Assets | 271.19M | 287.60M | 325.70M | 381.00M | 96.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 71.09M | 77.50M | 35.10M | 16.60M | 18.90M | |||
| Investments And Advances | 28.01M | 61.00M | 142.20M | N/A | N/A | |||
| Other Non-Current Assets | 6.17M | 4.80M | 3.80M | 2.60M | 2.60M | |||
| Total Non-Current Assets | 105.26M | 143.20M | 181.10M | 19.10M | 21.50M | |||
| TOTAL ASSETS | 376.45M | 430.80M | 506.80M | 400.10M | 118.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 2.30M | N/A | N/A | N/A | |||
| Accrued Expenses | 23.81M | 22.40M | 14.50M | 10.10M | 7.30M | |||
| Accounts Payable | 1.45M | 1.20M | 4.50M | 5.70M | 5.40M | |||
| Other Current Liabilities | 17.51M | 18.70M | 32.20M | 28.10M | 21.00M | |||
| Total Current Liabilities | 42.77M | 44.50M | 51.20M | 43.90M | 33.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 9.20M | 10.80M | 10.10M | 0.00 | |||
| Other Non-Current Liabilities | 87.57M | 87.90M | 55.10M | 65.40M | 85.60M | |||
| Total Non-Current Liabilities | 87.57M | 97.10M | 66.00M | 75.40M | 85.60M | |||
| TOTAL LIABILITIES | 130.34M | 141.60M | 117.20M | 119.30M | 119.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -528.38M | -395.90M | -267.70M | -183.80M | -117.50M | |||
| Additional Paid In Capital | 774.62M | 689.30M | 658.10M | 464.60M | 5.50M | |||
| Common Shares | 6.00K | 0.00 | 0.00 | 0.00 | 111.00M | |||
| Other Shareholders' Equity | -127.00K | -4.10M | -800.00K | 0.00 | N/A | |||
| Shares Outstanding | 60.47M | 49.00M | 48.70M | 43.10M | 41.50M | |||
| Tangible Book Value per Share | 4.07 | 5.90 | 8.00 | 6.52 | -2.70 | |||
| Total Shareholders' Equity | 246.11M | 289.20M | 389.60M | 280.80M | -1.00M | |||
| TOTAL LIABILITIES AND EQUITY | 376.45M | 430.80M | 506.80M | 400.10M | 118.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.03 | 0.03 | 0.04 | N/A | |||
| Current Ratio | 6.34 | 6.46 | 6.36 | 8.68 | 2.88 | |||
| Return On Assets (ROA) | -35.20% | -29.75% | -16.55% | -16.58% | -35.98% | |||
| Return On Equity (ROE) | -53.83% | -44.32% | -21.53% | -23.63% | N/A | |||
All data in USD